one of the most active chemotherapeutic regimens for treatment of advanced and recurrent head and neck cancer is cisplatin ( cacp ) + 5-fluorouracil ( 5-fu ) infusion with a response rate of 90 % in advanced , previously untreated patients and 70 % in patients with recurrent disease .
C1335703
recurrent head and neck cancer
C0277556
recurrent disease